243 related articles for article (PubMed ID: 17084562)
1. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
[TBL] [Abstract][Full Text] [Related]
2. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery.
Vaidya JS; Baum M; Tobias JS; Wenz F; Massarut S; Keshtgar M; Hilaris B; Saunders C; Williams NR; Brew-Graves C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Sütterlin M; Bulsara M; Joseph D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1091-7. PubMed ID: 20951505
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
5. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
[TBL] [Abstract][Full Text] [Related]
7. Prospective trial of intraoperative radiation treatment for breast cancer.
Joseph DJ; Bydder S; Jackson LR; Corica T; Hastrich DJ; Oliver DJ; Minchin DE; Haworth A; Saunders CM
ANZ J Surg; 2004 Dec; 74(12):1043-8. PubMed ID: 15574144
[TBL] [Abstract][Full Text] [Related]
8. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
[TBL] [Abstract][Full Text] [Related]
9. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
[TBL] [Abstract][Full Text] [Related]
10. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
11. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
12. Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays.
Herskind C; Griebel J; Kraus-Tiefenbacher U; Wenz F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1575-81. PubMed ID: 19028280
[TBL] [Abstract][Full Text] [Related]
13. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays.
Welzel G; Hofmann F; Blank E; Kraus-Tiefenbacher U; Hermann B; Sütterlin M; Wenz F
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():359-67. PubMed ID: 20853059
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.
Wenz F; Welzel G; Blank E; Hermann B; Steil V; Sütterlin M; Kraus-Tiefenbacher U
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1309-14. PubMed ID: 20100643
[TBL] [Abstract][Full Text] [Related]
16. Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancer.
Trombetta M; Julian TB; Valakh V; Greenberg L; Labban G; Khalid MK; Werts ED; Parda D
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1303-8. PubMed ID: 20044218
[TBL] [Abstract][Full Text] [Related]
17. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
Holmes DR; Baum M; Joseph D
Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
[TBL] [Abstract][Full Text] [Related]
18. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
19. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.
Jobsen JJ; van der Palen J; Ong F
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):115-22. PubMed ID: 18234450
[TBL] [Abstract][Full Text] [Related]
20. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]